Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angelo Gordon is a global alternative investment firm that specializes in credit and real estate, with a significant dedicated vertical in healthcare investing. Founded in 1988, the firm provides capital solutions to middle-market healthcare companies, focusing on sectors such as healthcare services, medical products, and pharmaceutical services. In November 2023, the firm was acquired by TPG, a leading global alternative asset management firm, and now operates as TPG Angelo Gordon. The healthcare team typically targets companies with strong management and defensive market positions, offering both equity and debt financing. The firm's healthcare portfolio has historically included investments in specialized pharmacy services, medical manufacturing, and clinical service providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angelo, Gordon & Co..